Sagimet Biosciences Stock (NASDAQ: SGMT) stock price, news, charts, stock research, profile.
Open | $3.00 |
Close | $3.11 |
Volume / Avg. | 1.09M / 548.55K |
Day Range | 2.90 - 3.15 |
52 Wk Range | 2.13 - 20.71 |
Market Cap | $99.25M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 8.49% |
Days to Cover | 3.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sagimet Biosciences (NASDAQ:SGMT) through any online brokerage.
Other companies in Sagimet Biosciences’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).
There is no analysis for Sagimet Biosciences.
Sagimet Biosciences has a consensus price target of $29.83.
The stock price for Sagimet Biosciences (NASDAQ: SGMT) is $3.11 last updated Today at July 8, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Sagimet Biosciences.
Sagimet Biosciences’s Q2 earnings are confirmed for Monday, August 19, 2024.
There is no upcoming split for Sagimet Biosciences.
Sagimet Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.